SCHEMBL6195071

SCHEMBL6195071

OC(COc1cccc2cccc(F)c12)CC1CNCCN1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
ADRB2 P07550 4/20 0.34
ADRB1 P08588 4/20 0.34
ADRB3 P13945 4/20 0.34
NR2E1 Q9Y466 2/20 0.34
LTA4H P09960 1/20 0.33
DRD4 P21917 1/20 0.33
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
LMNA P02545 2/20 0.32
GPR35 Q9HC97 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
POLB P06746 1/20 0.32
TLR4 O00206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6192033 0.87 HTR1A (0.42) KDM4ECYP1A2CYP2C19KMT2ALTA4H
SCHEMBL6193610 0.78 LMNA (0.52) KDM4EMEN1CYP1A2KMT2ALTA4H
SCHEMBL7280306 0.74 LTA4H (0.51) KDM4EADRB2ADRB1ADRB3LTA4H
SCHEMBL5901549 0.74 POLB (0.60) KDM4EMEN1CYP1A2CYP2C19KMT2A
SCHEMBL5995472 0.70 SLC6A2 (0.34) HTR1ALMNA
SCHEMBL15645462 0.68 LTA4H (0.55) LTA4HHTR1A
SCHEMBL15645465 0.68 LTA4H (0.55) LTA4HHTR1A
SCHEMBL6195068 0.67 PRKCQ (0.32) ADRB2ADRB1ADRB3
SCHEMBL8119772 0.66 LTA4H (0.52) LTA4HHTR1A
SCHEMBL6192019 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583751-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS, INC. (US) 2005-10-12 EP disclosed
WO-2004069818-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS INC. (US) 2004-08-19 WO disclosed